MB-CART19.1 r/r CD19+ B-cell Malignancies (BCM)

Clinical trial NCT03853616 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT03853616
Sponsor: Miltenyi Biomedicine GmbH
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Acute Lymphoblastic Leukemia Recurrent B-cell Lymphoma Recurrent B-cell Lymphoma Refractory Chronic Lymphocytic Leukemia Recurrent Chronic Lymphocytic Leukemia Refractory

Start date: 2018-11-26
Primary completion: 2026-09-01
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.